Oculomotor Schwannomas: A Systematic Review and Report of Two Pediatric Cases Treated with Fractionated Cyberknife Stereotactic Radiotherapy

Hassan A. Fadel, Tarek Y. El Ahmadieh, Aaron R. Plitt, Om J. Neeley, Zachary Johnson, Salah G. Aoun, O. Mohamad, Robert Timmerman, Bradley E. Weprin

Research output: Contribution to journalReview article

Abstract

Objective: Pediatric oculomotor nerve schwannomas are rare and challenging lesions due to the high morbidity associated with surgical intervention and their proximity to critical structures limiting the opportunity for stereotactic radiosurgery. We aim to report and review the novel use of fractionated Cyberknife (Accuray, Inc., Sunnyvale, California, USA) stereotactic radiotherapy in pediatric patients with oculomotor schwannomas. Methods: A systematic review of PubMed, Embase, and Cochrane was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Two patients, ages 8 and 10 years, with tumor volumes of 0.1 cm3 and 0.2 cm3, respectively, were treated with fractionated Cyberknife radiotherapy at our institution. A total dose of 45–50 Gy was administered over 25 fractions (1.8–2.0 Gy per fraction) to the 82%−84% isodose line. Serial magnetic resonance imaging was obtained for long-term follow-up (56–58 months). Results: We found 14 articles published between 1982 and 2018 that reported a total of 18 pediatric patients with intracranial oculomotor schwannomas. No previously described cases of pediatric intracranial oculomotor schwannomas were treated with radiation therapy. In both of our patients, radiographic tumor control was achieved at a mean follow-up of 57 months, with 1 patient displaying a decrease in tumor volume. Neither patient exhibited any worsening of their presenting symptoms, nor did either patient develop any new neurocognitive deficits following treatment. Conclusions: Fractionated Cyberknife radiotherapy is an effective and well-tolerated treatment option for intracranial oculomotor nerve schwannomas with excellent tumor control rates, similar to surgical and radiosurgical techniques, while sparing critical surrounding structures.

Original languageEnglish (US)
JournalWorld Neurosurgery
DOIs
StatePublished - Jan 1 2019

Fingerprint

Neurilemmoma
Radiotherapy
Pediatrics
Oculomotor Nerve
Tumor Burden
Radiosurgery
PubMed
Meta-Analysis
Neoplasms
Magnetic Resonance Imaging
Guidelines
Morbidity
Therapeutics

Keywords

  • Cyberknife
  • Fractionated radiotherapy
  • Oculomotor
  • Pediatric
  • Schwannoma

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Oculomotor Schwannomas : A Systematic Review and Report of Two Pediatric Cases Treated with Fractionated Cyberknife Stereotactic Radiotherapy. / Fadel, Hassan A.; El Ahmadieh, Tarek Y.; Plitt, Aaron R.; Neeley, Om J.; Johnson, Zachary; Aoun, Salah G.; Mohamad, O.; Timmerman, Robert; Weprin, Bradley E.

In: World Neurosurgery, 01.01.2019.

Research output: Contribution to journalReview article

@article{f348d34c91064aceb6bb2106e9fe8ec0,
title = "Oculomotor Schwannomas: A Systematic Review and Report of Two Pediatric Cases Treated with Fractionated Cyberknife Stereotactic Radiotherapy",
abstract = "Objective: Pediatric oculomotor nerve schwannomas are rare and challenging lesions due to the high morbidity associated with surgical intervention and their proximity to critical structures limiting the opportunity for stereotactic radiosurgery. We aim to report and review the novel use of fractionated Cyberknife (Accuray, Inc., Sunnyvale, California, USA) stereotactic radiotherapy in pediatric patients with oculomotor schwannomas. Methods: A systematic review of PubMed, Embase, and Cochrane was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Two patients, ages 8 and 10 years, with tumor volumes of 0.1 cm3 and 0.2 cm3, respectively, were treated with fractionated Cyberknife radiotherapy at our institution. A total dose of 45–50 Gy was administered over 25 fractions (1.8–2.0 Gy per fraction) to the 82{\%}−84{\%} isodose line. Serial magnetic resonance imaging was obtained for long-term follow-up (56–58 months). Results: We found 14 articles published between 1982 and 2018 that reported a total of 18 pediatric patients with intracranial oculomotor schwannomas. No previously described cases of pediatric intracranial oculomotor schwannomas were treated with radiation therapy. In both of our patients, radiographic tumor control was achieved at a mean follow-up of 57 months, with 1 patient displaying a decrease in tumor volume. Neither patient exhibited any worsening of their presenting symptoms, nor did either patient develop any new neurocognitive deficits following treatment. Conclusions: Fractionated Cyberknife radiotherapy is an effective and well-tolerated treatment option for intracranial oculomotor nerve schwannomas with excellent tumor control rates, similar to surgical and radiosurgical techniques, while sparing critical surrounding structures.",
keywords = "Cyberknife, Fractionated radiotherapy, Oculomotor, Pediatric, Schwannoma",
author = "Fadel, {Hassan A.} and {El Ahmadieh}, {Tarek Y.} and Plitt, {Aaron R.} and Neeley, {Om J.} and Zachary Johnson and Aoun, {Salah G.} and O. Mohamad and Robert Timmerman and Weprin, {Bradley E.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.wneu.2019.05.114",
language = "English (US)",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Oculomotor Schwannomas

T2 - A Systematic Review and Report of Two Pediatric Cases Treated with Fractionated Cyberknife Stereotactic Radiotherapy

AU - Fadel, Hassan A.

AU - El Ahmadieh, Tarek Y.

AU - Plitt, Aaron R.

AU - Neeley, Om J.

AU - Johnson, Zachary

AU - Aoun, Salah G.

AU - Mohamad, O.

AU - Timmerman, Robert

AU - Weprin, Bradley E.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Pediatric oculomotor nerve schwannomas are rare and challenging lesions due to the high morbidity associated with surgical intervention and their proximity to critical structures limiting the opportunity for stereotactic radiosurgery. We aim to report and review the novel use of fractionated Cyberknife (Accuray, Inc., Sunnyvale, California, USA) stereotactic radiotherapy in pediatric patients with oculomotor schwannomas. Methods: A systematic review of PubMed, Embase, and Cochrane was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Two patients, ages 8 and 10 years, with tumor volumes of 0.1 cm3 and 0.2 cm3, respectively, were treated with fractionated Cyberknife radiotherapy at our institution. A total dose of 45–50 Gy was administered over 25 fractions (1.8–2.0 Gy per fraction) to the 82%−84% isodose line. Serial magnetic resonance imaging was obtained for long-term follow-up (56–58 months). Results: We found 14 articles published between 1982 and 2018 that reported a total of 18 pediatric patients with intracranial oculomotor schwannomas. No previously described cases of pediatric intracranial oculomotor schwannomas were treated with radiation therapy. In both of our patients, radiographic tumor control was achieved at a mean follow-up of 57 months, with 1 patient displaying a decrease in tumor volume. Neither patient exhibited any worsening of their presenting symptoms, nor did either patient develop any new neurocognitive deficits following treatment. Conclusions: Fractionated Cyberknife radiotherapy is an effective and well-tolerated treatment option for intracranial oculomotor nerve schwannomas with excellent tumor control rates, similar to surgical and radiosurgical techniques, while sparing critical surrounding structures.

AB - Objective: Pediatric oculomotor nerve schwannomas are rare and challenging lesions due to the high morbidity associated with surgical intervention and their proximity to critical structures limiting the opportunity for stereotactic radiosurgery. We aim to report and review the novel use of fractionated Cyberknife (Accuray, Inc., Sunnyvale, California, USA) stereotactic radiotherapy in pediatric patients with oculomotor schwannomas. Methods: A systematic review of PubMed, Embase, and Cochrane was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Two patients, ages 8 and 10 years, with tumor volumes of 0.1 cm3 and 0.2 cm3, respectively, were treated with fractionated Cyberknife radiotherapy at our institution. A total dose of 45–50 Gy was administered over 25 fractions (1.8–2.0 Gy per fraction) to the 82%−84% isodose line. Serial magnetic resonance imaging was obtained for long-term follow-up (56–58 months). Results: We found 14 articles published between 1982 and 2018 that reported a total of 18 pediatric patients with intracranial oculomotor schwannomas. No previously described cases of pediatric intracranial oculomotor schwannomas were treated with radiation therapy. In both of our patients, radiographic tumor control was achieved at a mean follow-up of 57 months, with 1 patient displaying a decrease in tumor volume. Neither patient exhibited any worsening of their presenting symptoms, nor did either patient develop any new neurocognitive deficits following treatment. Conclusions: Fractionated Cyberknife radiotherapy is an effective and well-tolerated treatment option for intracranial oculomotor nerve schwannomas with excellent tumor control rates, similar to surgical and radiosurgical techniques, while sparing critical surrounding structures.

KW - Cyberknife

KW - Fractionated radiotherapy

KW - Oculomotor

KW - Pediatric

KW - Schwannoma

UR - http://www.scopus.com/inward/record.url?scp=85068400079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068400079&partnerID=8YFLogxK

U2 - 10.1016/j.wneu.2019.05.114

DO - 10.1016/j.wneu.2019.05.114

M3 - Review article

C2 - 31125775

AN - SCOPUS:85068400079

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

ER -